Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (6.671)

91

Combined Use of Tocilizumab and Mesenchymal Stem Cells Attenuate the Development of an Anti-HLA-A2.1 Antibody in a Highly Sensitized Mouse Model

in: International Journal of Molecular Sciences | 2024

von Xianying Fang | Sheng Cui | Hanbi Lee | +6

92

The association between tocilizumab and the secondary bloodstream infection maybe nonsignificant in hospitalized patients with SARS-CoV-2 infection: A cohort study

in: Journal of Microbiology, Immunology and Infection | 2024

von De-En Lu | Tsong-Yih Ou | Jyun-Wei Kang | +4

93

Successful high-dose glucocorticoid therapy for anti-mitochondrial antibody-positive myocarditis arising during tocilizumab and low-dose glucocorticoid therapy for rheumatoid arthritis

in: Immunological Medicine | 2024

von Koji Suzuki | Mitsuhiro Akiyama | Shuntaro Saito | +1

94

Tocilizumab Exerts Anti-Tumor Effects on Colorectal Carcinoma Cell Xenografts Corresponding to Expression Levels of Interleukin-6 Receptor

in: Pharmaceuticals | 2024

von Yuan-Chiang Chung | Szu-Jung Chen | Chiu-Chen Huang | +7

95

A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease

in: One Health & Risk Management | 2024

von Stela COJOCARU | Irina RUSSU | Galina BUTA | +4

96

The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study

in: Trials | 2024

von Lena Kreis | Christian Dejaco | Wolfgang Andreas Schmidt | +3

97

Combining immune‐checkpoint inhibitors with tocilizumab to treat a lung adenocarcinoma patient with pre‐existing polymyalgia rheumatica: A case report

in: Thoracic Cancer | 2024

von Yang Du | Xiao‐Yan Liu | Li Zhang

98

Early versus standard management of chimeric antigen receptor therapy toxicities and management's impact on safety and efficacy

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Gaffney, K. | Davis, J. | McGann, M. | +6

99

Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs : real life experience from the TReasure Registry

enthalten in: Clinical and experimental rheumatology | 2024

von Karadag, O. | Farisogullari, B. | Yagiz, B. | +23

100

Use of Tocilizumab Followed by Rituximab Desensitization on Relapsing Myelin Oligodendrocyte Antibody Disease : A Case Report

enthalten in: Cureus | 2024

von Dayrit, K. | Chua-Ley, E.